BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nicolini G, Ghosh-laskar S, Shrivastava SK, Banerjee S, Chaudhary S, Agarwal JP, Munshi A, Clivio A, Fogliata A, Mancosu P, Vanetti E, Cozzi L. Volumetric Modulation Arc Radiotherapy With Flattening Filter-Free Beams Compared With Static Gantry IMRT and 3D Conformal Radiotherapy for Advanced Esophageal Cancer: A Feasibility Study. International Journal of Radiation Oncology*Biology*Physics 2012;84:553-60. [DOI: 10.1016/j.ijrobp.2011.12.041] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Liu YM, Peng YL, Li QW, Shen G, Ma YR, Chen MN, Zhang J, Fu LR, Qiu B, Liu H, Deng XW. Computed Tomography-Based Evaluation of Volume and Position Changes of the Target Region and Organs at Risk During Radiotherapy for Esophageal Cancer: A Pilot Study. Front Oncol 2021;11:702400. [PMID: 34395275 DOI: 10.3389/fonc.2021.702400] [Reference Citation Analysis]
2 Liu X, Jin F, Luo H, Zhang X, Guo M, Zhao X, Wu F, Guo Q. Clinical impact of the flattening filter free irradiation in fixed-field IMRT and VMAT for stage I–II nasal natural killer/T-cell lymphoma. Journal of Radiation Research and Applied Sciences 2021;14:253-9. [DOI: 10.1080/16878507.2021.1948759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Sarkar RR, Hatamipour A, Panjwani N, Courtney PT, Cherry DR, Salans MA, Yip AT, Rose BS, Simpson DR, Banegas MP, Murphy JD. Impact of Radiation on Cardiovascular Outcomes in Older Resectable Esophageal Cancer Patients With Medicare. Am J Clin Oncol 2021;44:275-82. [PMID: 33782335 DOI: 10.1097/COC.0000000000000815] [Reference Citation Analysis]
4 Yang R, Yang X, Wang L, Li D, Guo Y, Li Y, Guan Y, Wu X, Xu S, Zhang S, Chan MF, Geng L, Sui J. Commissioning and clinical implementation of an Autoencoder based Classification-Regression model for VMAT patient-specific QA in a multi-institution scenario. Radiother Oncol 2021;161:230-40. [PMID: 34166717 DOI: 10.1016/j.radonc.2021.06.024] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Kodama T, Yasui K, Nishioka S, Miyaura K, Takakura T, Katayose T, Nakamura M. Survey on utilization of flattening filter-free photon beams in Japan. J Radiat Res 2021;62:726-34. [PMID: 34036361 DOI: 10.1093/jrr/rrab042] [Reference Citation Analysis]
6 Zhang W, Zhao J, Han W, Zhang H, Wang X, Li C, Chen J, Wang X, Zhao Y, Qiao X, Zhou Z, Han C, Zhu S, Shen W, Wang L, Ge X, Sun X, Zhang K, Hu M, Li L, Hao C, Li G, Xu Y, Wang Y, Lu N, Liu M, Qian S, Xiao Z, Wang P, Pang Q. Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03). Ann Transl Med 2020;8:1140. [PMID: 33240989 DOI: 10.21037/atm-20-4672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang L, Li J, Zhang S, Zhang X, Zhang Q, Chan MF, Yang R, Sui J. Multi-task autoencoder based classification-regression model for patient-specific VMAT QA. Phys Med Biol 2020;65:235023. [PMID: 33245054 DOI: 10.1088/1361-6560/abb31c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
8 Chow JCL. Depth Dose Enhancement on Flattening-Filter-Free Photon Beam: A Monte Carlo Study in Nanoparticle-Enhanced Radiotherapy. Applied Sciences 2020;10:7052. [DOI: 10.3390/app10207052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
9 Zhao J, Lei T, Zhang T, Chen X, Dong J, Guan Y, Wang J, Wei H, Er P, Han D, Wei X, Guo Z, Du Q, Wang J, Liu N, Song Y, Yuan Z, Zhao L, Zhang W, Pang Q, Wang P. The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma. Ann Transl Med 2020;8:1160. [PMID: 33241009 DOI: 10.21037/atm-20-4366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Moon SH, Suh YG. The Role of Modern Radiotherapy Technology in the Treatment of Esophageal Cancer. Korean J Thorac Cardiovasc Surg 2020;53:184-90. [PMID: 32793450 DOI: 10.5090/kjtcs.2020.53.4.184] [Reference Citation Analysis]
11 Celik E, Baus W, Baues C, Schröder W, Clivio A, Fogliata A, Scorsetti M, Marnitz S, Cozzi L. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer. Radiat Oncol 2020;15:120. [PMID: 32448296 DOI: 10.1186/s13014-020-01570-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang AD, Su XH, Shi GF, Han C, Wang L, Liu H, Zhang J, Zhang RH. Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. Arch Med Res 2020;51:419-28. [PMID: 32418649 DOI: 10.1016/j.arcmed.2020.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
13 Kirli Bolukbas M, Karaca S. Effect of lung volume on helical radiotherapy in esophageal cancer: are there predictive factors to achieve acceptable lung doses? Strahlenther Onkol 2020;196:805-12. [PMID: 31980833 DOI: 10.1007/s00066-020-01581-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li KJ, Xia XF, Su M, Zhang H, Chen WH, Zou CL. Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy. BMC Cancer 2019;19:1004. [PMID: 31655563 DOI: 10.1186/s12885-019-6157-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
15 Lin WC, Chang CL, Hsu HL, Yuan KS, Wu ATH, Wu SY. Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E1529. [PMID: 31658709 DOI: 10.3390/cancers11101529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Li J, Wang L, Zhang X, Liu L, Li J, Chan MF, Sui J, Yang R. Machine Learning for Patient-Specific Quality Assurance of VMAT: Prediction and Classification Accuracy. Int J Radiat Oncol Biol Phys 2019;105:893-902. [PMID: 31377162 DOI: 10.1016/j.ijrobp.2019.07.049] [Cited by in Crossref: 19] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
17 Wang L, Li C, Meng X, Li C, Sun X, Shang D, Pang L, Li Y, Lu J, Yu J. Dosimetric and Radiobiological Comparison of External Beam Radiotherapy Using Simultaneous Integrated Boost Technique for Esophageal Cancer in Different Location. Front Oncol 2019;9:674. [PMID: 31404144 DOI: 10.3389/fonc.2019.00674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
18 Flores-Martinez E, Kim GY, Yashar CM, Cerviño LI. Dosimetric study of the plan quality and dose to organs at risk on tangential breast treatments using the Halcyon linac. J Appl Clin Med Phys 2019;20:58-67. [PMID: 31183967 DOI: 10.1002/acm2.12655] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
19 Liu C, Bhangoo RS, Sio TT, Yu NY, Shan J, Chiang JS, Ding JX, Rule WG, Korte S, Lara P, Ding X, Bues M, Hu Y, DeWees T, Ashman JB, Liu W. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies. J Appl Clin Med Phys 2019;20:15-27. [PMID: 31112371 DOI: 10.1002/acm2.12623] [Cited by in Crossref: 13] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
20 Chen NB, Qiu B, Zhang J, Qiang MY, Zhu YJ, Wang B, Guo JY, Cai LZ, Huang SM, Liu MZ, Li Q, Hu YH, Li QW, Liu H. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities. Cancer Res Treat 2020;52:31-40. [PMID: 31048664 DOI: 10.4143/crt.2018.624] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
21 Chow JCL, Owrangi AM. Mucosal dosimetry on unflattened photon beams: a Monte Carlo phantom study. Biomed Phys Eng Express 2018;5:015007. [DOI: 10.1088/2057-1976/aaeaaa] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
22 Martini S, Arcadipane F, Strignano P, Spadi R, Contu V, Fiandra C, Ragona R, Catalano G, Satolli MA, Camandona M, Romagnoli R, Ricardi U, Franco P. Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients. Med Oncol 2018;35:150. [PMID: 30284647 DOI: 10.1007/s12032-018-1211-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
23 Ren X, Wang L, Han C, Ren L. Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma. Radiother Oncol 2018;129:293-9. [PMID: 30270099 DOI: 10.1016/j.radonc.2018.09.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
24 Shi L, Lai Y, Chen S, Fu L, Lin Q. Dosimetric superiority of IMRT with jaw tracking technique for whole esophagus and T-shaped field radiotherapy in advanced esophageal cancer. PLoS One 2018;13:e0202628. [PMID: 30183753 DOI: 10.1371/journal.pone.0202628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
25 Sekar Y, Thoelking J, Eckl M, Kalichava I, Sihono DSK, Lohr F, Wenz F, Wertz H. Characterization and clinical evaluation of a novel 2D detector array for conventional and flattening filter free (FFF) IMRT pre-treatment verification. Zeitschrift für Medizinische Physik 2018;28:134-41. [DOI: 10.1016/j.zemedi.2017.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Tamilarasu S, Saminathan M, Sharma SK, Pahuja A, Dewan A. Comparative Evaluation of a 6MV Flattened Beam and a Flattening Filter Free Beam for Carcinoma of Cervix – IMRT Planning Study. Asian Pac J Cancer Prev 2018;19:639-43. [PMID: 29580032 DOI: 10.22034/APJCP.2018.19.3.639] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Bhushan M, Yadav G, Tripathi D, Kumar L, Kishore V, Dewan A, Kumar G, Wahi IK, Gairola M. Dosimetric Analysis of Unflattened (FFFB) and Flattened (FB) Photon Beam Energy for Gastric Cancers Using IMRT and VMAT-a Comparative Study. J Gastrointest Cancer 2019;50:408-19. [PMID: 29520733 DOI: 10.1007/s12029-018-0080-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Xu C, Xi M, Komaki R, Balter PA, Huang M, Hobbs BP, Wang L, Lin SH. Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus. Adv Radiat Oncol 2017;2:325-32. [PMID: 29114599 DOI: 10.1016/j.adro.2017.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
29 Yang H, Feng C, Cai BN, Yang J, Liu HX, Ma L. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma. Dis Esophagus 2017;30:1-8. [PMID: 27629865 DOI: 10.1111/dote.12497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 0.2] [Reference Citation Analysis]
30 Chang CL, Tsai HC, Lin WC, Chang JH, Hsu HL, Chow JM, Yuan KS, Wu ATH, Wu SY. Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma. Radiother Oncol 2017;125:73-9. [PMID: 28923576 DOI: 10.1016/j.radonc.2017.08.025] [Cited by in Crossref: 44] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
31 Xu D, Li G, Li H, Jia F. Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e7685. [PMID: 28767597 DOI: 10.1097/MD.0000000000007685] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
32 Dobler B, Obermeier T, Hautmann MG, Khemissi A, Koelbl O. Simultaneous integrated boost therapy of carcinoma of the hypopharynx/larynx with and without flattening filter - a treatment planning and dosimetry study. Radiat Oncol 2017;12:114. [PMID: 28679448 DOI: 10.1186/s13014-017-0850-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
33 Xi M, Lin SH. Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer. Expert Rev Anticancer Ther 2017;17:635-46. [PMID: 28503964 DOI: 10.1080/14737140.2017.1331130] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
34 Chun SG, Skinner HD, Minsky BD. Radiation Therapy for Locally Advanced Esophageal Cancer. Surg Oncol Clin N Am 2017;26:257-76. [PMID: 28279468 DOI: 10.1016/j.soc.2016.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
35 Budgell G, Brown K, Cashmore J, Duane S, Frame J, Hardy M, Paynter D, Thomas R. IPEM topical report 1: guidance on implementing flattening filter free (FFF) radiotherapy. Phys Med Biol 2016;61:8360-94. [DOI: 10.1088/0031-9155/61/23/8360] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
36 Sarkar B, Pradhan A. Choice of appropriate beam model and gantry rotational angle for low-dose gradient-based craniospinal irradiation using volumetric-modulated arc therapy. J Radiother Pract 2017;16:53-64. [DOI: 10.1017/s146039691600042x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Vieillevigne L, Bessieres S, Ouali M, Lanaspeze C. Dosimetric comparison of flattened and unflattened beams for stereotactic body radiation therapy: Impact of the size of the PTV on dynamic conformal arc and volumetric modulated arc therapy. Physica Medica 2016;32:1405-14. [DOI: 10.1016/j.ejmp.2016.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
38 Rieber J, Tonndorf-martini E, Schramm O, Rhein B, Stefanowicz S, Kappes J, Hoffmann H, Lindel K, Debus J, Rieken S. Radiosurgery with flattening-filter-free techniques in the treatment of brain metastases: Plan comparison and early clinical evaluation. Strahlenther Onkol 2016;192:789-96. [DOI: 10.1007/s00066-016-1012-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
39 Nicolay NH, Rademacher J, Oelmann-avendano J, Debus J, Huber PE, Lindel K. High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer: Experience from a large single-center cohort. Strahlenther Onkol 2016;192:458-66. [DOI: 10.1007/s00066-016-0979-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
40 Yan Y, Yadav P, Bassetti M, Du K, Saenz D, Harari P, Paliwal BR. Dosimetric differences in flattened and flattening filter-free beam treatment plans. J Med Phys 2016;41:92-9. [PMID: 27217620 DOI: 10.4103/0971-6203.181636] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
41 Dobler B, Khemissi A, Obermeier T, Hautmann MG, Katsilieri Z, Kölbl O. Re-irradiating spinal column metastases using IMRT and VMAT with and without flattening filter - a treatment planning study. Radiat Oncol 2016;11:33. [PMID: 26932561 DOI: 10.1186/s13014-016-0603-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
42 Carrington R, Spezi E, Gwynne S, Dutton P, Hurt C, Staffurth J, Crosby T. The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial. Radiat Oncol 2016;11:19. [PMID: 26852238 DOI: 10.1186/s13014-016-0594-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Lu JY, Zheng J, Zhang WZ, Huang BT. Flattening Filter-Free Beams in Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy for Sinonasal Cancer. PLoS One 2016;11:e0146604. [PMID: 26734731 DOI: 10.1371/journal.pone.0146604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
44 Chuong MD, Hallemeier CL, Jabbour SK, Yu J, Badiyan S, Merrell KW, Mishra MV, Li H, Verma V, Lin SH. Improving Outcomes for Esophageal Cancer using Proton Beam Therapy. Int J Radiat Oncol Biol Phys. 2016;95:488-497. [PMID: 27084662 DOI: 10.1016/j.ijrobp.2015.11.043] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
45 Fogliata A, Nicolini G, Clivio A, Vanetti E, Laksar S, Tozzi A, Scorsetti M, Cozzi L. A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers. Radiat Oncol 2015;10:220. [PMID: 26521015 DOI: 10.1186/s13014-015-0530-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 9.3] [Reference Citation Analysis]
46 Huang BT, Lu JY, Lin PX, Chen JZ, Kuang Y, Chen CZ. Comparison of Two RapidArc Delivery Strategies in Stereotactic Body Radiotherapy of Peripheral Lung Cancer with Flattening Filter Free Beams. PLoS One 2015;10:e0127501. [PMID: 26131554 DOI: 10.1371/journal.pone.0127501] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
47 Zhang T, Liang ZW, Han J, Bi JP, Yang ZY, Ma H. Double-arc volumetric modulated therapy improves dose distribution compared to static gantry IMRT and 3D conformal radiotherapy for adjuvant therapy of gastric cancer. Radiat Oncol 2015;10:114. [PMID: 25986069 DOI: 10.1186/s13014-015-0420-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
48 Xiao Y, Kry SF, Popple R, Yorke E, Papanikolaou N, Stathakis S, Xia P, Huq S, Bayouth J, Galvin J, Yin FF. Flattening filter-free accelerators: a report from the AAPM Therapy Emerging Technology Assessment Work Group. J Appl Clin Med Phys 2015;16:5219. [PMID: 26103482 DOI: 10.1120/jacmp.v16i3.5219] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 12.4] [Reference Citation Analysis]
49 Wu AJ, Bosch WR, Chang DT, Hong TS, Jabbour SK, Kleinberg LR, Mamon HJ, Thomas CR Jr, Goodman KA. Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. Int J Radiat Oncol Biol Phys 2015;92:911-20. [PMID: 26104943 DOI: 10.1016/j.ijrobp.2015.03.030] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 9.3] [Reference Citation Analysis]
50 Lu JY, Cheung ML, Huang BT, Wu LL, Xie WJ, Chen ZJ, Li DR, Xie LX. Improving target coverage and organ-at-risk sparing in intensity-modulated radiotherapy for cervical oesophageal cancer using a simple optimisation method. PLoS One 2015;10:e0121679. [PMID: 25768733 DOI: 10.1371/journal.pone.0121679] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
51 Feng Z, Wu H, Zhang Y, Zhang Y, Cheng J, Su X. Dosimetric comparison between jaw tracking and static jaw techniques in intensity-modulated radiotherapy. Radiat Oncol 2015;10:28. [PMID: 25623899 DOI: 10.1186/s13014-015-0329-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
52 Zhang W, Lin Z, Yang Z, Fang W, Lai P, Lu J, Wu VW. Evaluation of the dosimetric impact of applying flattening filter-free beams in intensity-modulated radiotherapy for early-stage upper thoracic carcinoma of oesophagus. J Med Radiat Sci 2015;62:108-13. [PMID: 26229675 DOI: 10.1002/jmrs.93] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
53 Créhange G, Quivrin M, Vulquin N, Serre A, Maingon P. Chimioradiothérapie des cancers de l’œsophage : quelles aires ganglionnaires faut-il irradier ? Cancer/Radiothérapie 2014;18:577-82. [DOI: 10.1016/j.canrad.2014.07.150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
54 Fu G, Li M, Song Y, Dai J. A dosimetric evaluation of flattening filter-free volumetric modulated arc therapy in nasopharyngeal carcinoma. J Med Phys 2014;39:150-5. [PMID: 25190993 DOI: 10.4103/0971-6203.139003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
55 Roeder F, Nicolay NH, Nguyen T, Saleh-Ebrahimi L, Askoxylakis V, Bostel T, Zwicker F, Debus J, Timke C, Huber PE. Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer. Radiat Oncol 2014;9:191. [PMID: 25175056 DOI: 10.1186/1748-717X-9-191] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
56 Chow JC, Owrangi AM. Dosimetric dependences of bone heterogeneity and beam angle on the unflattened and flattened photon beams: A Monte Carlo comparison. Radiation Physics and Chemistry 2014;101:46-52. [DOI: 10.1016/j.radphyschem.2014.03.041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
57 Gasic D, Ohlhues L, Brodin NP, Fog LS, Pommer T, Bangsgaard JP, Munck Af Rosenschöld P. A treatment planning and delivery comparison of volumetric modulated arc therapy with or without flattening filter for gliomas, brain metastases, prostate, head/neck and early stage lung cancer. Acta Oncol 2014;53:1005-11. [PMID: 24937551 DOI: 10.3109/0284186X.2014.925578] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
58 Munshi A. Radiation oncology: Colors and hues. South Asian J Cancer 2014;3:16-7. [PMID: 24665440 DOI: 10.4103/2278-330X.126505] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Dzierma Y, Nuesken FG, Palm J, Licht NP, Ruebe C. Planning study and dose measurements of intracranial stereotactic radiation surgery with a flattening filter-free linac. Practical Radiation Oncology 2014;4:e109-16. [DOI: 10.1016/j.prro.2013.04.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
60 Akino Y, Ota S, Inoue S, Mizuno H, Sumida I, Yoshioka Y, Isohashi F, Ogawa K. Characteristics of flattening filter free beams at low monitor unit settings. Med Phys 2013;40:112101. [PMID: 24320454 DOI: 10.1118/1.4824920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
61 Lechner W, Kragl G, Georg D. Evaluation of treatment plan quality of IMRT and VMAT with and without flattening filter using Pareto optimal fronts. Radiother Oncol 2013;109:437-41. [PMID: 24183067 DOI: 10.1016/j.radonc.2013.09.020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
62 Zavgorodni S. Monte Carlo investigation into feasibility and dosimetry of flat flattening filter free beams. Phys Med Biol 2013;58:7699-713. [PMID: 24140752 DOI: 10.1088/0031-9155/58/21/7699] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
63 Lobefalo F, Bignardi M, Reggiori G, Tozzi A, Tomatis S, Alongi F, Fogliata A, Gaudino A, Navarria P, Cozzi L, Scorsetti M, Mancosu P. Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case. Radiat Oncol 2013;8:176. [PMID: 23837942 DOI: 10.1186/1748-717X-8-176] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
64 Chan MK, Kwong DL, Law GM, Tam E, Tong A, Lee V, Ng SC. Dosimetric evaluation of four-dimensional dose distributions of CyberKnife and volumetric-modulated arc radiotherapy in stereotactic body lung radiotherapy. J Appl Clin Med Phys 2013;14:4229. [PMID: 23835388 DOI: 10.1120/jacmp.v14i4.4229] [Cited by in Crossref: 20] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
65 Zhuang M, Zhang T, Chen Z, Lin Z, Li D, Peng X, Qiu Q, Wu R. Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams. Radiat Oncol 2013;8:120. [PMID: 23672519 DOI: 10.1186/1748-717X-8-120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
66 Shridhar R, Almhanna K, Meredith KL, Biagioli MC, Chuong MD, Cruz A, Hoffe SE. Radiation Therapy and Esophageal Cancer. Cancer Control 2013;20:97-110. [DOI: 10.1177/107327481302000203] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
67 Buergy D, Lohr F, Baack T, Siebenlist K, Haneder S, Michaely H, Wenz F, Boda-Heggemann J. Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy. Radiat Oncol. 2012;7:192. [PMID: 23157945 DOI: 10.1186/1748-717x-7-192] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
68 Boylan C, McWilliam A, Johnstone E, Rowbottom C. The impact of continuously-variable dose rate VMAT on beam stability, MLC positioning, and overall plan dosimetry. J Appl Clin Med Phys 2012;13:4023. [PMID: 23149797 DOI: 10.1120/jacmp.v13i6.4023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
69 Alongi F, Clerici E, Pentimalli S, Mancosu P, Scorsetti M. Initial experience of hypofractionated radiation retreatment with true beam and flattening filter free beam in selected case reports of recurrent nasopharyngeal carcinoma. Rep Pract Oncol Radiother 2012;17:262-8. [PMID: 24669306 DOI: 10.1016/j.rpor.2012.07.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
70 Shridhar R, Chuong MD, Weber J, Freilich J, Almhanna K, Coppola D, Dinwoodie W, Dilling TJ, Fernandez D, Karl RC, Meredith KL, Hoffe SE. Outcomes of definitive or preoperative IMRT chemoradiation for esophageal cancer. J Radiat Oncol 2012;1:347-54. [DOI: 10.1007/s13566-012-0048-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]